Drugs / NVP-1603-2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03220399 | Dec 2019 → Mar 2020 | — | NVP Healthcare | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NVP-1603-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03220399 ↗ |
| Route | Oral | “1tablet, single oral dosing” NCT03220399 ↗ |